Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulised procaterol versus nebulised salbutamol for moderate acute asthma
ISRCTN25669625Phase 3Completed
- Sponsor
- Otsuka Holdings
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of procaterol and salbutamol in acute severe asthma, sponsored by Otsuka Holdings. Primary endpoint: Difference from baseline in peak expiratory flow rate at 120 minutes. Started Jun 2007; status: completed.
02
Drugs
procaterolsalbutamol
03
Conditions
acute severe asthma
Beyond the preview
Go deeper on ISRCTN25669625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN25669625.